Ceftriaxone sodium and Hyperkalemia - a phase IV clinical study of FDA data
Summary:
Hyperkalemia is reported as a side effect among people who take Ceftriaxone sodium (ceftriaxone sodium), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Fluconazole, and have High blood pressure.
The phase IV clinical study analyzes which people have Hyperkalemia when taking Ceftriaxone sodium. It is created by eHealthMe based on reports of 6,546 people who have side effects when taking Ceftriaxone sodium from the FDA, and is updated regularly.
What is Ceftriaxone sodium?
Ceftriaxone sodium has active ingredients of ceftriaxone sodium. eHealthMe is studying from 6,549 Ceftriaxone sodium users. Check the latest studies of Ceftriaxone sodium.
What is Hyperkalemia?
Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,951 drugs and 2,941 conditions by eHealthMe. Check the latest studies of Hyperkalemia.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
6,546 people reported to have side effects when taking Ceftriaxone sodium.
Among them, 64 people (0.98%) have Hyperkalemia.

Among these 64 people:
How long have people been on Ceftriaxone sodium when they have Hyperkalemia? *
- < 1 month: 93.94 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 6.06 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Hyperkalemia when taking Ceftriaxone sodium? *
- female: 23.33 %
- male: 76.67 %
What is the age of people who have Hyperkalemia when taking Ceftriaxone sodium? *
- 0-1: 0.0 %
- 2-9: 1.75 %
- 10-19: 15.79 %
- 20-29: 1.75 %
- 30-39: 7.02 %
- 40-49: 5.26 %
- 50-59: 14.04 %
- 60+: 54.39 %
What are other drugs people take besides Ceftriaxone sodium? *
- Fluconazole: 10 people, 15.62%
- Albuterol: 8 people, 12.50%
- Dexamethasone: 8 people, 12.50%
- Lasix: 7 people, 10.94%
- Sulfamethoxazole And Trimethoprim: 7 people, 10.94%
- Xarelto: 7 people, 10.94%
- Gabapentin: 7 people, 10.94%
- Meropenem: 7 people, 10.94%
- Prednisolone Acetate: 6 people, 9.38%
- Darunavir: 6 people, 9.38%
What are other side effects people have besides Hyperkalemia? *
- Diarrhea: 11 people, 17.19%
- Haemoglobin Decreased: 11 people, 17.19%
- Haemolysis (breaking open of red blood cells and the release of haemoglobin into the surrounding fluid): 10 people, 15.62%
- Hypokalemia (low potassium): 8 people, 12.50%
- Anaemia (lack of blood): 7 people, 10.94%
- Weakness: 7 people, 10.94%
- Renal Impairment (severely reduced kidney function): 7 people, 10.94%
- Cardiac Arrest: 7 people, 10.94%
- Pneumonia: 7 people, 10.94%
- Thrombocytopenia (decrease of platelets in blood): 6 people, 9.38%
What are the existing conditions these people have? *
- High Blood Pressure: 10 people, 15.62%
- Hiv Infection: 9 people, 14.06%
- Diabetes: 7 people, 10.94%
- Hypokalemia (low potassium): 7 people, 10.94%
- Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 10.94%
- Asthma: 6 people, 9.38%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 5 people, 7.81%
- Pneumonia: 5 people, 7.81%
- Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 5 people, 7.81%
- Pulmonary Tuberculosis (lungs tuberculosis): 5 people, 7.81%
* Approximation only. Some reports may have incomplete information.
Do you take Ceftriaxone sodium and have Hyperkalemia?
- Check whether Hyperkalemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ceftriaxone sodium:
- Ceftriaxone sodium (6,549 reports)
Hyperkalemia treatments and more:
- Hyperkalemia (78,085 reports)
How severe was Hyperkalemia and when was it recovered:
Expand to all the drugs that have ingredients of ceftriaxone sodium:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ceftriaxone sodium:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Hyperkalemia:
- Hyperkalemia (1,951 drugs)
Browse all the conditions that are associated with Hyperkalemia:
- Hyperkalemia (2,941 conditions)
Related publications that referenced our studies
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
- Agrawal SR, Rajput A, Jain AP, "Leukocytoclastic vasculitis and acute allergic interstitial nephritis following ceftriaxone exposure", Journal of pharmacology & pharmacotherapeutics, 2014 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on ceftriaxone sodium (the active ingredients of Ceftriaxone sodium) and Ceftriaxone sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Bactrim Ds and Zoledronic Acid - now
- Drug interactions of Nasonex and Tylenol - 3 seconds ago
- Could Lactobacillus Rhamnosus cause Weight Increased? - 4 seconds ago
- Could Fludrocortisone Acetate cause Exposed Bone In Jaw? - 6 seconds ago
- Could Proair Hfa cause Infusion Related Reaction? - 15 seconds ago
- Could Carvedilol cause Tremor? - 16 seconds ago
- Arthritis and Lung Neoplasm - 17 seconds ago
- Could Ubrelvy cause Musculoskeletal Stiffness? - 18 seconds ago
- Could Carvedilol cause Thrombotic Microangiopathy? - 24 seconds ago
- Could Pantethine cause Pleural Effusion? - 27 seconds ago